Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors).

Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors). Transplant Cell Ther. 2024 Nov; 30(11):1100.e1-1100.e11.

View in: PubMed

subject areas

Adult
Aged
Antigens, CD34
Cord Blood Stem Cell Transplantation
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Primary Myelofibrosis
Tissue Donors
Transplantation, Homologous
Treatment Outcome
Unrelated Donors

authors with profiles

Koen Van Besien